These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8846383)

  • 21. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 22. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M; Hashizume K
    Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glimepiride for NIDDM.
    Med Lett Drugs Ther; 1996 May; 38(975):47-8. PubMed ID: 8632731
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
    Ravina A; Minuhin O
    Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
    [No Abstract]   [Full Text] [Related]  

  • 25. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 26. Pioglitazone/glimepiride (Duetact) for diabetes.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypoglycemic sulfamides: new pharmacologic data and practical implications].
    Blickle JF; Brogard JM
    Diabetes Metab; 1998 Jun; 24(3):276-80. PubMed ID: 9690064
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes care: what should we try to achieve?
    O'Connor PJ
    J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].
    Mazurov VI; Novik AA; Nagibovich OA; Romashevskiĭ BV; Guliaeva IV; Kurganova TA
    Klin Med (Mosk); 1998; 76(6):38-41. PubMed ID: 9693499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 33. [Increased blood sugar in type 2 diabetes mellitus: what now?].
    Winter T
    Praxis (Bern 1994); 2002 Mar; 91(12):498-502. PubMed ID: 11974431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonylurea treatment in type 2 diabetes.
    Bester K; Ton J; Korownyk C
    Can Fam Physician; 2018 Apr; 64(4):295. PubMed ID: 29650607
    [No Abstract]   [Full Text] [Related]  

  • 35. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 37. Gliquidone contributes to improvement of type 2 diabetes mellitus management: a review of pharmacokinetic and clinical trial data.
    Malaisse WJ
    Drugs R D; 2006; 7(6):331-7. PubMed ID: 17073516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summaries for patients. How do older diabetes drugs compare in their effects on heart and blood vessel disease?
    Ann Intern Med; 2012 Nov; 157(9):I-28. PubMed ID: 23128878
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hardly any hypoglycemias, constant weight--and still cost effective].
    MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.